Category Archives: Global

The UK's New "Revolutionary" Medicines Optimization Plan

By Guest Blogger | Published: May 21, 2013
By Leela Barham. The UK’s Royal Pharmaceutical Society has joined forces with a number of other organizations, including the Association of the British Pharmaceutical Industry (ABPI), to issue new guidance on medicines optimization.  Sir Bruce Keogh, Medical Director of NHS England, says it could be revolutionary.
Also posted in Europe, Guest Blog, Op-Ed | Tagged , , , , , , | Leave a comment

Global Biosimilars Market to Reach $2.4 Billion in 2013

By Guest Blogger | Published: May 17, 2013
By Adeline Siew, Editor, Pharmaceutical Technology Europe. The global market for biosimilar drugs has been forecasted to be worth $2.445 billion this year, according to a new report by British market research specialist Visiongain. The growth represents a 20% increase from last year and accounts for approximately 2% of the overall biologics market. Moreover, the global [...]
Also posted in Biotech, Guest Blog, R&D | Tagged , , , | Leave a comment

Catch On to Content Marketing

By Guest Blogger | Published: May 7, 2013
Pharma should have a head start in the content marketing race, but familiar fears are holding it back, writes Peter Houston. You know this: digital marketing means you have the potential to get your message in front of more people than ever before; search and social media offer reach on an unparalleled scale. According to global [...]
Also posted in Europe, Guest Blog, Marketing, Op-Ed | Leave a comment

PhRMA Dismayed by Global IPR Report

By Guest Blogger | Published: May 6, 2013
Also posted in Guest Blog, IP, Regulatory | Tagged , , , | Leave a comment

A Global Consensus: Oncologists Spooked By Health Reforms

By Clark Herman | Published: April 26, 2013
In a recent survey by Ipsos Healthcare, oncologists from the US, China, Brazil, and the EU Big 5, expressed strong dissatisfaction with the direction and pace of local healthcare initiatives. Conducted in February of this year, the survey indicates that a substantial portion of its 257 respondents—an average of 40% across these markets – are [...]
Also posted in Market Access, Regulatory, pricing | Tagged , , , , | Leave a comment